BTW
CRI icon

Boston Trust Walden’s Carter's CRI Stock Holding History

Boston Trust Walden’s Portfolio CRI Stock Details CRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-512,211
Closed -$27.8M – 379
2024
Q4 		$27.8M Sell
512,211
-131,133
-20% -$7.51M 0.19% 164
2024
Q3 		$41.8M Sell
643,344
-414,984
-39% -$26.7M 0.29% 137
2024
Q2 		$65.6M Sell
1,058,328
-76,932
-7% -$5.34M 0.49% 69
2024
Q1 		$96.1M Buy
1,135,260
+168
+0% +$13.3K 0.69% 43
2023
Q4 		$85M Buy
1,135,092
+3,570
+0.3% +$248K 0.64% 45
2023
Q3 		$78.2M Buy
1,131,522
+40,896
+4% +$2.92M 0.66% 45
2023
Q2 		$79.2M Buy
1,090,626
+98,339
+10% +$6.64M 0.65% 45
2023
Q1 		$71.4M Buy
992,287
+26,906
+3% +$2.06M 0.62% 52
2022
Q4 		$72M Buy
965,381
+187,551
+24% +$13.4M 0.63% 53
2022
Q3 		$51M Buy
777,830
+16,835
+2% +$1.29M 0.5% 62
2022
Q2 		$53.6M Buy
760,995
+10,261
+1% +$826K 0.51% 64
2022
Q1 		$69.1M Buy
750,734
+39,275
+6% +$3.69M 0.57% 51
2021
Q4 		$72M Buy
711,459
+15,919
+2% +$1.62M 0.58% 45
2021
Q3 		$67.6M Buy
695,540
+4,633
+0.7% +$468K 0.6% 44
2021
Q2 		$71.3M Buy
690,907
+22,217
+3% +$2.26M 0.63% 41
2021
Q1 		$59.5M Buy
668,690
+30,857
+5% +$2.85M 0.58% 49
2020
Q4 		$60M Buy
637,833
+207,088
+48% +$18.2M 0.64% 41
2020
Q3 		$37.3M Buy
430,745
+120,492
+39% +$10M 0.46% 64
2020
Q2 		$25M Buy
310,253
+162,240
+110% +$12.9M 0.34% 90
2020
Q1 		$9.73M Buy
148,013
+3,519
+2% +$339K 0.16% 182
2019
Q4 		$15.8M Buy
144,494
+2,823
+2% +$286K 0.18% 163
2019
Q3 		$12.9M Buy
141,671
+1,385
+1% +$126K 0.16% 180
2019
Q2 		$13.7M Buy
140,286
+25,962
+23% +$2.53M 0.18% 169
2019
Q1 		$11.5M Buy
114,324
+4,050
+4% +$361K 0.16% 173
2018
Q4 		$9M Buy
+110,274
New +$10M 0.14% 188

Other funds holding CRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RWWM Inc Rocklin, California $1.35B AUM 9.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Boston Trust Walden's CRI Position: Q1 2025 in Review

Boston Trust Walden sold out of Carter's (CRI) in Q1 2025, closing a stake of 512,211 shares — an estimated $27.8M sold.

Boston Trust Walden first reported a position in CRI in Q4 2018 and held it in 25 quarters. The position peaked at $96.1M in Q1 2024. 286 funds tracked by Wall St. Rank hold CRI as of Q1 2025.

  • Boston Trust Walden reported no remaining Carter's position as of Q1 2025 after selling out during the quarter.
  • Boston Trust Walden sold 512,211 Carter's shares in Q1 2025, an estimated $27.8M.
  • Boston Trust Walden first reported a position in Carter's in Q4 2018 and held it in 25 quarters.
  • Boston Trust Walden's Carter's position peaked at $96.1M in Q1 2024.
  • 286 funds tracked by Wall St. Rank held Carter's as of Q1 2025.

Based on Boston Trust Walden's 13F filing for Q1 2025, filed 21 Apr 2025.